Aclarion, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACON research report →
Price Chart
About the company
Aclarion, Inc. , a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications.
- CEO
- Brent Ness
- IPO
- 2022
- Employees
- 11
- HQ
- Broomfield, CA, US
Get TickerSpark's AI analysis on ACON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.52M
- P/E
- -0.22
- PEG
- -0.00
- P/S
- 35.75
- P/B
- 0.23
- EV/EBITDA
- 1.08
- Div Yield
- 0.00%
- Gross Margin
- -32.75%
- Op Margin
- -10789.22%
- Net Margin
- -10260.05%
- ROE
- -62.91%
- ROIC
- -71.82%
Latest fiscal year · YoY change
- Revenue
- $75.73K+65.6%
- Gross Profit
- $-220,578-162.5%
- Op Income
- $-7,052,391
- Net Income
- $-7,233,629-3.4%
- EPS
- $-13.61+99.8%
- OCF Growth
- -35.9%
- FCF Growth
- -28.5%
- 52W High
- $9.36
- 52W Low
- $1.22
- 50D MA
- $2.06
- 200D MA
- $2.71
- Beta
- 1.21
- RSI (14)
- 26
- Avg Volume
- 34.73K
No earnings-call transcripts are available for ACON yet.
- Free Float
- 70.9%
- Shares Outstanding
- 2.88M
- Float Shares
- 2.04M
of shares held by institutions
15 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Citadel Advisors LLC | 63.53K | ▲ 63.53K |
| Captrust Financial Advisors | 40.00K | ▲ 22.94K |
| Bridgeway Capital Management, LLC | 19.48K | 0 |
| Vanguard Fiduciary Trust Co | 16.03K | 0 |
| Jane Street Group, LLC | 14.69K | ▲ 14.69K |
| Geode Capital Management, LLC | 12.07K | ▼ 60 |
| Xtx Topco Ltd | 10.63K | ▼ 410 |
| Mosaic Family Wealth Partners, LLC | 10.00K | ▲ 10.00K |
| Bank Of Montreal /Can/ | 10.00K | 0 |
| Osaic Holdings, Inc. | 7.50K | ▲ 2.50K |
| Vanguard Capital Management LLC | 6.78K | 0 |
| Fmr LLC | 1.00K | ▲ 1.00K |
Held by 5 ETFs
Biggest fund positions in ACON by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 19, 26 | Gould Gregory A | buy | 3,388 |
| Aug 17, 26 | Williams Amanda M | buy | 5,857 |
| Aug 14, 26 | Gould Gregory A | buy | 10,000 |
| Aug 13, 26 | Bond Ryan | buy | 21,122 |
| Aug 13, 26 | Wesemann William | buy | 2,150 |
| Aug 13, 26 | Neal David K | buy | 7,500 |
| Aug 13, 26 | Ness Brent | buy | 5,234 |
| Jun 11, 26 | Bond Ryan | other | 55,000 |
| Jun 11, 26 | Sequira Amanda Mae | other | 20,000 |
| Jun 11, 26 | Breidbart Scott | other | 20,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ACON coverage
Recent articles, reports, and earnings notes.
No research on ACON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACON report →Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
prismmediawire.com · Oct 22
Aclarion to Present at the 20th Annual LD Micro Main Event
globenewswire.com · Oct 13
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
prismmediawire.com · Oct 8
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
globenewswire.com · Oct 8
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
prismmediawire.com · Sep 29
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
globenewswire.com · Sep 29
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update
defenseworld.net · Sep 28
Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)
defenseworld.net · Sep 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.